Comparable long-term outcomes between upfront haploidentical and identical sibling donor transplant in aplastic anemia: a national registry-based study

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains a curative option for severe aplastic anemia (SAA), and transplantation from identical sibling donors (ISD) has been recommended as a first-line treatment. Haploidentical donor (HID) transplantation for SAA has made great advance...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Zheng-Li, Xu, Lan-Ping, Wu, De-Pei, Wang, Shun-Qing, Zhang, Xi, Xi, Rui, Gao, Su-Jun, Xia, Ling-Hui, Yang, Jian-Min, Jiang, Ming, Wang, Xin, Liu, Qi-Fa, Chen, Jia, Zhou, Ming, Huang, Xiao-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Article - Quality of Life
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713560/
https://www.ncbi.nlm.nih.gov/pubmed/35615930
http://dx.doi.org/10.3324/haematol.2022.280758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713560/
https://www.ncbi.nlm.nih.gov/pubmed/35615930
http://dx.doi.org/10.3324/haematol.2022.280758

Ejemplares similares